Request Appointment
1400 S Orange AveOrlando, FL 32806
Overview of Dr. Shah
Dr. Nikita Shah is an oncologist in Orlando, FL and is affiliated with Orlando Health Orlando Regional Medical Center. She received her medical degree from Baroda Medical College and has been in practice 26 years. Dr. Shah accepts several types of health insurance, listed below. She is one of 68 doctors at Orlando Health Orlando Regional Medical Center who specialize in Oncology. She has 5 publications and over 500 citings.
Education & Training
McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 1998 - 1999
Presence Saint Francis HospitalFellowship, Hematology, 1996 - 1997
Ascension Illinois/Saint FrancisResidency, Internal Medicine, 1993 - 1996
Baroda Medical CollegeClass of 1991
Certifications & Licensure
FL State Medical License 1999 - 2026
IL State Medical License 1993 - 2002
American Board of Internal Medicine Medical Oncology
ABIMMedical Oncology and Hematology
Awards, Honors, & Recognition
- Best Doctors Orlando Magazine, 2007-2018
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Dec 10
- Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer Start of enrollment: 2011 May 16
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- Join now to see all
Publications & Presentations
PubMed
- 9 citationsA Phase II Single-arm Study of Palbociclib in Patients With HER2-positive Breast Cancer With Brain Metastases and Analysis of ctDNA in Patients With Active Brain Metas...Ami N Shah, Cesar A Santa-Maria, Dhruvika Mukhija, Nikita Shah, Anthony K Kang
Clinical Breast Cancer. 2023-04-01 - 554 citationsSacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer.Aditya Bardia, Ingrid A. Mayer, Linda T. Vahdat, Sara M. Tolaney, Steven J. Isakoff
The New England Journal of Medicine. 2019-02-20 - 42 citationsLCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.Amanda E.D. Van Swearingen, Marni B. Siegel, Allison M. Deal, Maria J. Sambade, Alan P. Hoyle
Breast Cancer Research and Treatment. 2018-06-25
Press Mentions
1 in 5 Young Women Has No Plans to Get a MammogramSeptember 29th, 2022- Survey Finds Alarming Number of Young Women Have No Plans of Getting MammogramsSeptember 28th, 2022
- Survey: 22% of Women Aged 35 to 44 Have Never Gotten a Mammogram, Have No Plans to Get OneSeptember 28th, 2022
- Join now to see all
Professional Memberships
- Member
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
AvMed Health Open Access
BCBS Blue Card PPO
BCBS Florida BlueCare HMO
BCBS Florida NetworkBlue
BCBS Florida Preferred Patient Care PPO
BCBS Illinois BlueChoice Select
BCBS Illinois HMO
BCBS Illinois PPO
CIGNA HMOCIGNA Open Access
CIGNA PPO
Coventry Florida - Employer Group PPO
First Health PPO
Great West PPO
HealthLink PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
